ODI PHARMA AB Net Asset Momentum
ODI PHARMA AB net asset momentum. ODI PHARMA AB (6OD) recorded a net asset momentum of 459.4% as of June 2026, with net assets of €2.38 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check 6OD cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of ODI PHARMA AB (2022–2026)
Net asset momentum of ODI PHARMA AB from 2022 to 2026. This chart tracks ODI PHARMA AB's year-over-year net asset growth across 5 annual reporting periods from 2022 to 2026. The most recent momentum reading is +459.4%, with net assets of €2.38 Million EUR as of June 2026. See ODI PHARMA AB shareholders equity for net asset value and shareholders' equity analysis.
ODI PHARMA AB Net Asset Momentum by Year (2022–2026)
ODI PHARMA AB net asset momentum by year from 2022 to 2026. The table below shows the complete annual net asset history for ODI PHARMA AB from 2022 to 2026, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 6OD company net worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | €2.38 Million | €5.30 Million | €2.93 Million | ▲ +459.4% |
| 2025 | €424.64K | €4.61 Million | €4.19 Million | ▼ -78.8% |
| 2024 | €2.00 Million | €12.23 Million | €10.23 Million | ▼ -22.2% |
| 2023 | €2.57 Million | €8.19 Million | €5.61 Million | ▼ -72.2% |
| 2022 | €9.26 Million | €10.50 Million | €1.24 Million | — |